Iingenelelo kunye neziNzuzo zoKhuseleko lwe-Allergy Shots
Kusenokwenzeka ukuba uye wakuva ukuba ukunyuka kwe-immunotherapy okanye i-cluster immunotherapy yindlela yokulawula ukunyuka kwakho ngokukhawuleza, kunye nokuzinikezela ixesha elingaphantsi komgca. Ziziphi na iinkqubo, ziphi iingenelo kunye nokuphazamiseka, kwaye zeziphi iindawo eziza kunceda kakhulu? Yintoni ekufuneka uyicinge malunga nokwenza isigqibo esona sigqibo?
Immunotherapy for Allergies and Asthma
I-Immunotherapy , okanye i-shorteristic shots, inikezela kuphela ukwelashwa kwimizimba ye-rhinitis , i -conjunctivitis ye-allergen , i - atopic dermatitis , i -asthma ye-inflammatory kunye ne-venom allergies. Ngokungafani nemichiza efihlakeleyo iimpawu eziqhekezayo, ukunyuka kwezilwanyana zonyango kuphela yonyango ukutshintsha indlela umzimba womntu ojongene ngayo nokunyamezela. Ucinga ngoko ke, ukuba wonke umntu angathanda ukwenza ukukhwabanisa. Ngelishwa, ukutshatyalaliswa kwezinto ezingahambi kakuhle kungabangela ukuba abantu abaninzi bangabonakali ngenxa yokuba zibandakanya ukuzibophelela kwexesha eliqhelekileyo (ngokuqhelekileyo ukuya kwiofisi ye-allergen once ukuya kabini ngeveki ekuqaleni), kwaye kungathatha inyanga ngaphambi kokuba baqale ukusebenza.
Iishedyuli zokukhawuleza ngokukhawuleza (ukukhawuleza) zokusetyenziswa kwamagqabi athatywayo zisetyenzisiwe ngabanye abagulisa i-allergen ukuze bafikelele kumlinganiselo ophezulu wokungabikho kokukhawuleza ngokukhawuleza, okubangela ukuzuza kwezibhengezo ngokukhawuleza. Ezi shedyuli nazo zikhokelela ekubeni umntu afike "kwimizi yesondlo" ngokukhawuleza, kunye nokukwazi ukuza kwiofisi yezilwanyana ezingapheliyo ngokukhawuleza ukukhangela umonakalo xa le dose yesondlo ifumaneka.
Kukho iindidi ezimbini zokuqulunqa ngokukhawuleza iishedyuli-i-immunotherapy ye-rush kunye ne-cluster immunotherapy.
Ziyintoni I-Rush Immunotherapy?
Ukukhupha i-immunotherapy kubandakanya ukunika umntu amaninzi amanxeba okudityaniswa kwimizuzu emininzi kwiiyure ukuya kwiintsuku, ukufikelela kwimizi yesondlo ngexesha elifutshane kakhulu. Ngokuqhelekileyo, ukunyuka kwamayeza kunikwa yonke imizuzu engama-15 ukuya kwimizuzu engama-60 kwithuba leentsuku ukuya kwiintsuku ezintathu ekuqaleni kwaye kwandiswe ngokukhawuleza ukuya kumayeza okugcina.
Inzuzo
Ukunyuka kwe-immunotherapy kuvumela abantu ukuba bafike kwi-doses yokugcina izifo zabo zokungabikho komzimba ngokukhawuleza. Oku kufuthi kufikelelwe kwiiveki ezintandathu. Ngokwahlukileyo, kunye neentlobo eziqhelekileyo zokungabikho komzimba, abantu bafumana amanani angatshatanga kunye okanye kabini ngeveki kwaye kungathabatha iinyanga ezintathu ukuya ezintandathu ukwakha ukuya kumayeza okugcina. Emva kwexesha lokuqala lokunyuka kwe-immunotherapy, umntu unako ukuza kwiofisi ye-allergen ngokuphindwe kanye ngeveki kwiiveki ezizayo, ngoko kungaphantsi kangangoko.
Abantu abajongene nokunyuka kwe-immunotherapy bafumana inzuzo ekungabikho kwemfutho ekhuselekileyo ngokukhawuleza, ngokuqhelekileyo kwiiveki ezimbalwa. Ukuxhamla nge-standard allergies shots kunokuthatha ixesha elide, kunye neenzuzo ngokuqhelekileyo ziqala malunga nexesha apho ukulungiswa kwamanani okufezekiswayo kufumaneka.
Ukunyuka kwe-immunotherapy kusetyenziswa abantu abantu abaneengxaki zokungabikho komzimba (i-bee sting allergies kunye ne-ant ant-sting allergies.) Oku kukuvumela ukukhusela ngokukhawuleza ekuphenduleni ukuphazamiseka kwezilwanyana ezizayo, kwaye ngokwenene kungaba yindlela ekhuselekileyo yokuphatha abantu abaneengxaki zenyama ingxaki ngeempembelelo ezichasayo kwiindawo zabo zokungabikho komzimba. Ucwaningo lwango-2016 lufumene i-immunotherapy yokukhawuleza ukuba ikhuseleke kwaye iphumelele ngokunyanzeliswa kwintlungu kubantwana.
Emva kwexesha elide, ukunyuka kwe-immunotherapy kungaphaya kwexabiso eliphezulu.
Iingxaki
Ngelishwa, ukunyuka kwe-immunotherapy kubangela ukuphendulwa kwegazi kwipesenti enkulu yabantu, ngoko ke amayeza amaninzi (njengama- antihistamine kunye ne- corticosteroids ) kaninzi anikezelwa ukwenzela ukukhusela okanye ukunciphisa le mpendulo. Umntu ojongene nokunyuka kwe-immunotherapy kufuneka alungiselele ukuchitha ubuncinane iintsuku ezimbalwa kwiofisi ye-allergenist, enokufumana amaninzi amaninzi okudityaniswa kwexesha lokudityaniswa kwelo xesha.
Ukukhawuleza kuninzi ixesha lokuzinikela phambili, ngokuqhelekileyo kuthatha ixesha elipheleleyo okanye ngaphezulu, ngelixa lidla ngokunciphisa ixesha lokuzibophelela kwexesha.
Iyintoni iCluster Immunotherapy?
I-Cluster immunotherapy iwela kwindawo ethile phakathi kwe-immunotherapy kunye nokunyuka kwe-immunotherapy kwinqanaba lezonyuka. Nge-cluster immunotherapy, amaninzi amayeza angama-2 ukuya kweathathu (okwenyuka kwamanani) anikezelwa rhoqo. Kucingelwa ukuba ngale ndlela, ukulungiswa kwe-dosing kungafezwa ngeeveki ezine ukuya kweyesibhozo (ngokungafani neenyanga ezintathu ukuya ezintandathu.) Njengoko ukukhupha i-immunotherapy ngokukhawuleza, le ndlela ivumela umntu ukuba afumane i-dosage yokukhawuleza ngokukhawuleza kodwa enomngcipheko ophezulu wokuphendula . Ngokuqhelekileyo, iipilisi zincinci zimbalwa zifunwa ngokubanzi kunokuba zifikelele kwi-immunotherapy
Okukwintsusa
Ukukhawuleza kunye ne-cluster immunotherapy kunika enye i-shedyuli yendabuko yokukhwabanisa, ukuvumela umntu ukuba afikelele kumazinga aphezulu okukhwabanisa ngokukhawuleza, ngoko ke athole inzuzo ngokukhawuleza. Nangona kunjalo, ukunyuka kwe-immunotherapy ngokukhawuleza kubangele izinga lokunyuka kweempendulo. Ukukhawuleza kuninzi ixesha lokuzibophelela phambili, ngokuqhelekileyo kuthatha ixesha elipheleleyo okanye ngaphezulu, ngelixa liza kuba ngumlondolozi wexesha kamva.
Ngokuqhelekileyo, i-allergists ineendlela eziqhelekileyo zokunika izigulane zabo izigulane, kwaye bavame ukunikezela ngesakhiwo esiqhelekileyo sokwakha kuzo zonke izigulane zabo. Uninzi lwazo zonke izigulane alubaniki izigulane zabo ukhetho lwexesha lokwakha. Ukuba unomdla wokusukela enye yale shedyuli yokwakha ngokukhawuleza, qhagamshelana nabaninzi bezilwanyana zezilwanyana endaweni yakho ukuze ufumane umntu onamava kule nkqubo.
Imithombo:
I-Confino-Cohen, R., Rosman, Y., no-A. Goldberg. Rush Venom Immunotherapy kwabantwana. I-Journal ye-allergies kunye ne-Clinic Immunology. KuSebenza . 2016 Novemba 30. (Epub phambi kokuprinta).
I-Cox, L. Iingenelo kunye Nezibonelelo eziPhezulu zeeNkqubo ze-Immunotherapy. I-Journal ye-allergies kunye ne-Clinic Immunology . 2008. 122 (2): 432-434.
Fan, Q., Liu, X., Gao, J., Huang, S., kunye noL. Ni. Uhlalutyo lokuqhathaniswa kweCluster Versus Conventional Immunotherapy kwizigulane ezine-Rhinitis ye-allergen. Uvavanyo lweMvavanyo kunye neyeza . 2017. 13 (2): 717-722.
Perez-Rangel, I., Rogriguez Del Rio, P., Escudero, C., Sanchez-Garcia, S., uSanchez-Hernandez, J., noMnumzane Ibanez. Ukusebenza kunye noKhuseleko lwe-High-Dose Rush Oral Immunotherapy kwi-Egg eqhubekayo Egg Abantwana: I-Trial Clinic Trial Trial. Ama-Annal of Allergy, i-Asthma kunye ne-Immunology . 2017. 118 (3): 356-364.
Winslow, A., Turbyville, J., Sublett, JW., Sublett, JL. noS. Pollard. Ukuthelekiswa kweempendulo zemiSebenzi kwiRush, Cluster, kunye ne-Standard-Yakha i-Aeroallergen Immunotherapy. Ama-Annal of Allergy, i-Asthma, kunye ne-Immunotherapy . 2016. 117 (5): 542-545.